CAFs are central architects of the TME, driving tumor progression through extracellular matrix (ECM) remodeling, immunosuppression, and secretion of pro-tumorigenic factors (e.g., TGF-β, IL-6, CXCL12). Here, CXCL12 is linked to neoplasm.